Tarsus Pharmaceuticals Inc (TARS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.88B
Last updated: Nov 17, 2026 at 4:20 PM ET
Tarsus Pharmaceuticals Inc (TARS) Stock Chart
Tarsus Pharmaceuticals (TARS) has a latest price of $78.20 on Nov 17, 2026, 14.6% below its 52-week high of $91.53. Its price rose 7.2% over the past 12 months. The month-end price rose 169.6% over the 5 years through Oct 2026, a compound annual rate of 21.9%.
Price Chart
From Oct 2020 to Oct 2026, its highest month-end close was $81.88 in Dec 2025 and its lowest $12.57 in Mar 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart TARS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for TARS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 6.5%, and over 6 months it rose 27.6%. The month-end price rose 425.6% over the 3 years through Oct 2026, a compound annual rate of 73.9%.
| Period | Change |
|---|---|
| 1 month | +12.5% |
| 3 months | +6.5% |
| 6 months | +27.6% |
| 12 months | +7.2% |
| 12 months, with dividends | +7.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +425.6% | +73.9% |
| 5 years | +169.6% | +21.9% |
Price by Year
Its best calendar year was 2024, when the price rose 173.4%, and its weakest was 2021, when it fell 45.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $74.85 | -8.6% |
| 2025 | $81.88 | +47.9% |
| 2024 | $55.37 | +173.4% |
| 2023 | $20.25 | +38.1% |
| 2022 | $14.66 | -34.8% |
| 2021 | $22.50 | -45.6% |
Trading Range
The price is 5.1% above its 50-day average of $74.42 and 14.8% above its 200-day average of $68.10.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $78.20 | |
| 52-week high | $91.53 | -14.6% |
| 52-week low | $53.89 | +45.1% |
| 50-day average | $74.42 | +5.1% |
| 200-day average | $68.10 | +14.8% |
Price Risk
Over 3 years, its largest fall from a peak was 45.1%.
| Measure | Value |
|---|---|
| 1-year beta | 0.60 |
| Largest fall, 1 year | -32.0% |
| Largest fall, 3 years | -45.1% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About TARS
What is TARS's 1-year price change?
Tarsus Pharmaceuticals's price rose 7.2% over the past 12 months. With dividends included, the 12-month total return was 7.2%.
What is TARS's 5-year price change?
Tarsus Pharmaceuticals's month-end price rose 169.6% over the 5 years through Oct 2026, a compound annual rate of 21.9%. These figures leave out dividends.
What is TARS's 52-week high and low?
Tarsus Pharmaceuticals's 52-week high is $91.53 and its 52-week low is $53.89. Its latest price of $78.20 on Nov 17, 2026 is 14.6% below the high.
What is TARS's beta?
Tarsus Pharmaceuticals's 1-year beta against the S&P 500 is 0.60, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 32.0%.
Is the TARS chart free?
Yes. Advanced Charting for TARS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
TARS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors